Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant staphylococcus aureus

Clinical Infectious Diseases

Volumn 55, Issue 6, 2012, Pages 781-788

  Tattevin, Pierre ^a   Schwartz, Brian S ^a   Graber, Christopher J ^b,c   Volinski, Joann ^a   Bhukhen, Akta ^a   Bhukhen, Arti ^a   Mai, Thuy T ^a   Vo, Nhung H ^a   Dang, Denise N ^a   Phan, Tiffany Haivan ^a   Basuino, Li ^a   Perdreau Remington, Françoise ^a   Chambers, Henry F ^a   Diep, Binh An ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; CLONAL VARIATION; DRUG USE; EPIDEMIC; FEMALE; GENOTYPE; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EPIDEMICS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR TYPING; RETROSPECTIVE STUDIES; SAN FRANCISCO; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; YOUNG ADULT;

EID: 84865503254     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis527     Document Type: Review

References (35)

1. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004; 190:1730-8. (Pubitemid 39487815)
2. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7:178-82. (Pubitemid 32374323)
3. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375: 1557-68.
4. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42:647-56. (Pubitemid 43271378)
5. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46(suppl 5):S344-9. (Pubitemid 351717321)
6. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillinresistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144: 309-17. (Pubitemid 46768185)
7. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53. (Pubitemid 40471452)
8. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23:616-87.
9. Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis 2009; 48 (suppl 4):S231-7.
10. Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis 2009; 48(suppl 4):S254-9.
11. Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis 2008; 46:1568-77. (Pubitemid 351706738)
12. Fowler VG Jr., Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163:2066-72. (Pubitemid 37151249)
13. Marchaim D, Kaye KS, Fowler VG, et al. Case-control study to identify factors associated with mortality among patients with methicillinresistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16:747-52.
14. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-43.
15. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52:285-92.
16. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-41.
17. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71. (Pubitemid 47598444)
18. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 2008; 46:1637-46. (Pubitemid 351706759)
19. Tattevin P, Diep BA, Jula M, Perdreau-Remington F. Long-term follow-up of methicillin-resistant Staphylococcus aureus molecular epidemiology after emergence of clone USA300 in San Francisco jail populations. J Clin Microbiol 2008; 46:4056-7.
20. Tattevin P, Diep BA, Jula M, Perdreau-Remington F. Methicillinresistant Staphylococcus aureus USA300 clone in long-term care facility. Emerg Infect Dis 2009; 15:953-5.
21. Jenkins TC, McCollister BD, Sharma R, et al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 2009; 30:233-41.
22. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: CG Mayhall , ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams and Wilkins, 2004:1672-89.
23. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137:791-7. (Pubitemid 35334450)
24. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37:3556-63. (Pubitemid 29491091)
25. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillinresistant Staphylococcus aureus. Lancet 2006; 367:731-9. (Pubitemid 43326291)
26. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrugresistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148:249-57. (Pubitemid 351665484)
27. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44:108-18. (Pubitemid 43100588)
28. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113-20. (Pubitemid 37429924)
29. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15. (Pubitemid 30140551)
30. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
31. Bancroft EA. Antimicrobial resistance: it's not just for hospitals. JAMA 2007; 298:1803-4. (Pubitemid 47598451)
32. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006; 119:943-51. (Pubitemid 44634301)
33. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillinresistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009; 301: 727-36.
34. Kreisel KM, Stine OC, Johnson JK, et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections? Diagn Microbiol Infect Dis 2011; 70: 285-90.
35. Hota B, Lyles R, Rim J, et al. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clin Infect Dis 2011; 53:757-65.